HEPATIC ANGIOSARCOMA

This adverse event was reported 73 times

These drugs are most commonly taken by patients reporting HEPATIC ANGIOSARCOMA:

# Drug Count
0 TACROLIMUS 16
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 16
2 TACROLIMUS OINTMENT 0.1% 16
3 PREDNISONE 13
4 EVEROLIMUS 10
5 EVEROLIMUS TABLETS 10
6 DOXORUBICIN 9
7 TESTOSTERONE 9
8 AZATHIOPRINE 6
9 CARMUSTINE 6
See all common drugs associated with HEPATIC ANGIOSARCOMA

HEPATIC ANGIOSARCOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IBRITUMOMAB TIUXETAN 6 0.0039
1 CARMUSTINE 6 0.0013
2 VELAGLUCERASE ALFA 2 0.0010
3 EVEROLIMUS TABLETS 10 0.0006
4 ARSENIC TRIOXIDE 1 0.0004
5 TESTOSTERONE 9 0.0004
6 SIROLIMUS 4 0.0003
7 MELPHALAN HYDROCHLORIDE 6 0.0002
8 EVEROLIMUS 10 0.0002
9 MYCOPHENILIC ACID 4 0.0002
See all drugs enriched for association with HEPATIC ANGIOSARCOMA